The application of Panax notoginseng with a focus on its anti-inflammatory effect: a narrative review
Authors:
- Sunggun KimSKSunggun Kim
- Sun-Jung HurSHSun-Jung Hur
- Duk-Sook YangDYDuk-Sook Yang
Open Access
- 1 December 2025
- journal article
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 13 (6) , 80
Abstract
Background and Objective: Panax notoginseng (P. notoginseng) has traditionally been used to support circulatory health. Its higher ginsenoside content and the presence of notoginsenoside R1 distinguish it from Panax ginseng and contribute to broader therapeutic potential. This review summarizes the anti-inflammatory mechanisms of P. notoginseng and their relevance to cardiovascular, hepatic, and metabolic disorders. Methods: A structured search of PubMed, Web of Science, Scopus, and Google Scholar was performed on December 20, 2024, covering January 2010 to July 2024. Studies published in English that provided mechanistic insights into anti-inflammatory activity in relation to P. notoginseng were included. Commentaries and studies without mechanistic detail were excluded. Screening was conducted independently by two authors. Key Content and Findings: P. notoginseng modulates key inflammatory pathways—including nuclear factor-κB (NF-κB), modulating mitogen-activated protein kinase (MAPK), cytokine regulation, oxidative stress, and endothelial function—supporting its benefits in vascular injury, liver inflammation, metabolic dysfunction, and gut-liver axis imbalance. Its unique phytochemical profile explains its stronger cardiovascular and hepatoprotective actions compared to P. ginseng. Conclusions: The broad pharmacological activities of P. notoginseng are largely driven by its anti-inflammatory mechanisms. These findings provide a framework for its clinical relevance and highlight the need for further translational and integrative research.Keywords
This publication has 55 references indexed in Scilit:
- Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation—The key step of inflammationBiochemical Pharmacology, 2011
- Radix/Rhizoma Notoginseng extract (Sanchitongtshu) for ischemic stroke: A randomized controlled studyPhytomedicine, 2011
- Hypolipidemic and antioxidant activities of Sanchi (Radix Notoginseng) in rats fed with a high fat dietPhytomedicine, 2011
- Ginsenoside Rb1 and paeoniflorin inhibit transient receptor potential vanilloid-1-activated IL-8 and PGE2 production in a human keratinocyte cell line HaCaTInternational Immunopharmacology, 2010
- Antiobesity and Antihyperglycemic Effects of Ginsenoside Rb1 in RatsDiabetes, 2010
- The Influence ofSam-Chil-Geun(Panax Notoginseng) on the Serum Lipid Levels and Inflammations of Rats with Hyperlipidemia Induced by Poloxamer-407Yonsei Medical Journal, 2010
- Ginsenosides Rb1 and Rg1 Suppress Triglyceride Accumulation in 3T3-L1 Adipocytes and Enhance β-Cell Insulin Secretion and Viability in Min6 CellsviaPKA-Dependent PathwaysBioscience, Biotechnology, and Biochemistry, 2008
- Toll-like receptor ligand-induced activation of murine DC2.4 cells is attenuated by Panax notoginsengJournal of Ethnopharmacology, 2008
- Inflammation and insulin resistanceJournal of Clinical Investigation, 2006
- Panax notoginseng attenuates LPS-induced pro-inflammatory mediators in RAW264.7 cellsJournal of Ethnopharmacology, 2006